Biosceptre appoints Sir Greg Winter as Chairman of the Board
Biosceptre is pleased to announce the appointment of Sir Greg [...]
Biosceptre is pleased to announce the appointment of Sir Greg [...]
28th September, 2016 Daniel Barton spoke with Fintan Walton of [...]
Press Release - Biosceptre announces today that Professor Francesco Di [...]
Biosceptre represented at the 2nd Annual Immuno-Oncology: BD&L and Investment [...]
Biosceptre announces today that Sir Gregory Winter, founder of Cambridge [...]
Cambridge, UK, 8th February 2016 – Biosceptre, a biopharmaceutical company developing
Cambridge, UK, 20 October 2014. Biosceptre, the oncology company developing antibody products
Cambridge, UK, 23rd July 2014. Biosceptre, the oncology company developing antibody products
Paper concludes Biosceptre's target nf-P2X7 is ubiquitous to all cancer [...]
Award to develop new therapeutic antibodies targeting nf-P2X7 to treat cancer [...]